arrow
M

Michele Arcopinto

IRCCS Policlinico San Donato
H指数:25
被引数:2,160

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study

乳铁蛋白、溶菌酶、乳酸杆菌、白藜芦醇、维生素和微量元素联合治疗对Post-COVID-19综合征患者运动能力的有益影响: 一项单中心回顾性研究

2024-07-290
OAAI
Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment
2023-03-0810
OAAI
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways

探索抗癌治疗的心脏毒性谱: 定义,分类和诊断途径

2023-02-173
OAAI
Acute Heart Failure: Diagnostic-Therapeutic Pathways and Preventive Strategies-A Real-World Clinician's Guide
2023-01-207
OAAI
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O. S.CA. registry
2022-09-225
OA
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the TOSCA. Registry
2022-06-1612
OAAI
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the TOSCA. registry
2022-04-218
OAAI
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the TOSCA. Registry
2021-03-0724
OAAI
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
2021-01-2916
OA
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure
2020-03-2615
PREAI